Juan Jose Badimon

15PUBLICATIONS
24CO-AUTHORS
Molecular medicineEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 04, 2025
Sotagliflozin: Two Birds with One Stone?

Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G Santos-Gallego

|Jul 03, 2024
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?

Carlos A Gongora, Lili Zhang, Juan Lopez Mattei

|Jun 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.

Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez

|Apr 12, 2023
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction.

Carlos G Santos-Gallego, Juan Antonio Requena-Ibáñez, Belen Picatoste

|Feb 25, 2023
Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors.

Ariana P Vargas-Delgado, Estefania Arteaga Herrera, Cesar Tumbaco Mite

Pageof 3